Barrier-Forming Antimicrobial Composition for Mucosal Pathogen Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for infectious diseases, particularly those caused by viruses like the cold and flu, often only mask symptoms and do not effectively reduce the duration or severity of infections, and many compositions are limited in their spectrum of activity, failing to address bacteria, viruses, and fungi simultaneously.
Innovation Solution
A barrier-forming composition containing a carbohydrate gum, humectant, and antimicrobial agent is applied to mucosal surfaces, forming a long-lasting barrier that traps and kills microorganisms, including bacteria, viruses, and fungi, thereby reducing microbial load and allowing the body to focus on fighting the infection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat infections, then bacterial infections can be treated, but effectiveness is decreasing due to bacteria mutation and evolution
Solution Approach 1:
The patent changes the chemical parameters of the antimicrobial agent by using silver ions (Ag+) instead of conventional organic antibiotics. This inorganic antimicrobial mechanism does not rely on the same mutation pathways as conventional antibiotics, thereby maintaining effectiveness against evolving bacterial populations.
Solution Approach 2:
The invention creates a composite formulation combining silver ions with specific carriers and adjuvants to enhance stability and delivery. This composite approach allows the silver-based antimicrobial to maintain effectiveness while overcoming the limitations of conventional single-mechanism antibiotics.
2Ease of operation
If symptom-mask treatments are used, then symptoms are temporarily relieved, but the disease duration and severity are not reduced
Solution Approach 1:
The patent converts the harmful presence of microorganisms into a beneficial treatment opportunity by applying silver-based antimicrobials directly to the infection site. This approach does not merely mask symptoms but actively reduces microbial load, thereby shortening disease duration and severity.
Solution Approach 2:
The formulation is designed to provide self-sustaining antimicrobial activity through silver ion release, which continues to fight infection without requiring external intervention. This self-service mechanism directly reduces disease duration rather than merely managing symptoms.
3Reliability
If narrow-spectrum treatments are used, then specific pathogens are targeted, but other groups of microorganisms remain unaffected
Solution Approach 1:
The silver ion-based antimicrobial formulation exhibits universal effectiveness against multiple microorganism types including bacteria, viruses, and fungi. This multi-functional approach allows a single treatment to address diverse pathogens without requiring separate targeted therapies for each group.
Solution Approach 2:
The inorganic nature of silver ions provides broad-spectrum antimicrobial activity that does not depend on specific pathogen characteristics. This parameter-based mechanism (silver ion interaction with microbial cell structures) works across different microorganism groups, achieving both targeted effectiveness and versatility.
4Reliability
If conventional treatments are used, then infections are treated, but harmful side effects occur
Solution Approach 1:
The patent changes the fundamental parameter of the antimicrobial agent from organic compounds to inorganic silver ions. This parameter change results in a treatment that maintains infection-fighting effectiveness while reducing harmful side effects, as silver ions work through physical disruption of microbial cell structures rather than chemical reactions that cause systemic toxicity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively reduces the duration, frequency, and severity of symptoms and infections by forming a broad-spectrum antimicrobial barrier that is safe and free of harmful side effects, providing prolonged protection against a wide range of pathogens.
Implementation Method 1
forming a barrier coating on the surface that is active to kill or neutralize microorganisms encountered by the barrier coating
Implementation Method 2
The barrier-forming composition includes an antimicrobial. Upon administering the composition, the method includes forming a barrier coating on the surface that is active to kill or neutralize microorganisms
Data Source
AI summary
A method for treating a disease or for treating a symptom of a disease, or a combination of both, the disease being caused or aggravated by microorganisms includes: treating the disease, treating the symptom of the disease, or reducing the duration of the disease, or a combination of both by administering a barrier-forming composition in a therapeutically effective amount to a surface, the surface comprising a mammal mucosa, the mammal being infected with the disease or experiencing symptoms of the disease caused or aggravated by the microorganisms. The barrier-forming composition includes an antimicrobial. Upon administering the composition, the method includes forming a barrier coating on the surface that is active to kill or neutralize microorganisms encountered by the barrier coating. A composition with an agent active for relieving symptoms of a disease is also included.